Choosing Mission Over Money
The Institute for OneWorld Health has discovered that addressing the world’s most menacing health threats sometimes means leaving money on the table. The organization, which is the nation’s first nonprofit pharmaceutical company, develops medications to tackle diseases in the developing world. Because drug development can take as many as 10 years from drawing board to regulatory approval, OneWorld Health has chosen to focus solely on its mission.
After the Asian tsunami, though, wealthy donors and well-known foundations offered OneWorld Health hefty sums to do emergency work in Asia. Michael MacHarg had to say no. “It’s tough," notes MacHarg, who, as…
Subscription Required
You must be a subscriber to read this article in its entirety. Access to Stanford Social Innovation Review full text online is restricted to paid print subscribers.
Subscribers
To login, please enter your login and password below. Login instructions were sent to the email address you provided upon receipt of payment
*Forgot your username or password? Click here
*Other problems logging in? Email
Not a Subscriber?
Subscribe and you will receive:
* Unlimited access to online articles. You will be emailed instructions for online access upon receipt of payment
* Delivery of the quarterly print magazine delivered to your home or office
* Full access to subscriber-only portions of the SSIR Web site
* Special discounts to Jossey Bass, Social Enterprise Alliance, Fieldstone Alliance
* Exclusive invitations to events and web seminars
Subscribe Now
Subscriber Login
Post a Comment
